FDA will drop two-study requirement for new drug approvals, aiming to speed access
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals
WFTV Now
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals
